Company / Working Capital per Share
Amylyx Pharmaceuticals, Inc. Working Capital per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$2.74
FY2025
5-year range
$2.35 / $47.79
FY2021-FY2025
Trend
+16.7%
vs FY2024
Sector context
#149 of 210
Health Care
What the data says
At $2.74, Amylyx Pharmaceuticals, Inc.'s working capital per share ranks #149 of 210 in the Health Care sector. Working Capital per Share returned to growth in FY2025 after 2 years of decline, reaching $2.74.
Based on SEC 10-K filings.
2.74 in FY2025 with a 3-year CAGR of -61.4%.
Declined from $5.65 to $2.74 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -61.4%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#149 of 210 in Health CareTop 71% of 210This company $2.74 Sector average $146.86
▼
-98.1% below sector average
Key checks
Key Insights
- In FY2025, working capital per share increased 16.7% year-over-year.
- Ranks #149 out of 210 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2022.
- Lowest working capital per share in the period was in FY2024.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.74 | +16.7% |
| FY2024 | $2.35 | -58.5% |
| FY2023 | $5.65 | -88.2% |
| FY2022 | $47.79 | +259.5% |
| FY2021 | $13.29 | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026